Cargando…
The Expression Level of BRCA2 and Its Changes during Chemotherapy in Patients with Different Pathological Types of Mammary Cancer
BACKGROUND: We aimed to investigate the expression level of breast cancer susceptibility gene 2 (BRCA2) and its changes during chemotherapy in patients with different pathological types of mammary cancer (MC). METHODS: Overall, 102 patients treated in Affiliated Tumor Hospital of Guangxi Medical Uni...
Autores principales: | HUANG, Yu, LUO, Min, HUANG, Junqing, HUANG, Shaoxin, WEI, Liuxia, ZHANG, Yumei, ZHANG, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825661/ https://www.ncbi.nlm.nih.gov/pubmed/31700821 |
Ejemplares similares
-
Relationship between three novel SNPs of BRCA1 and canine mammary
tumors
por: SUN, Weidong, et al.
Publicado: (2015) -
Reduced canine BRCA2 expression levels in mammary gland tumors
por: Yoshikawa, Yasunaga, et al.
Publicado: (2015) -
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
por: Huo, Yanying, et al.
Publicado: (2021) -
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors
por: Choi, Eun Kyung, et al.
Publicado: (2018) -
Characterization of primary mammary epithelial cells with loss of BRCA1 at a single cell level
por: Nakles, Rebecca E, et al.
Publicado: (2013)